At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 268 enrolled
Drug / intervention
DFN-11 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
DFN-11 Injection in Episodic Migraine With or Without Aura
In Brief
A Phase 3 clinical trial evaluating DFN-11 and Placebo for Episodic Migraine. Completed, enrolled 268 participants across 16 sites.
Detailed Summary
Safety and Efficacy of DFN-11 in patients with episodic migraines with or without aura.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEpisodic Migraine
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20162017201820192020202120222023202420252026
Enrollment StartSep 2015
First PostedOct 2015
Primary CompletionMay 2017
Study CompletionFeb 2018
TodayJul 2026
First PostedOct 7, 2015
Enrollment StartSep 21, 2015
Primary CompletionMay 30, 2017
Study CompletionFeb 26, 2018
TodayJul 2, 2026
Enrollment to primary: 1.7 yearsPosted 10.7 years ago
Interventions
DFN-11drug
Placeboother